Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
AAM Warns Hikma Case Risks Narrowing Skinny-Label Path To ‘Vanishing Point’
Association Says Carve-Out Shield Has Become Sword Wielded Against Generics Industry
Sep 09 2024
•
By
Dave Wallace
The AAM cautions that the scope of ‘skinny labels’ is narrowing • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin